These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 9252133)

  • 1. Elevated glomerular and blood mononuclear lymphocyte nitric oxide production in rats with chronic bile duct ligation: role of inducible nitric oxide synthase activation.
    Criado M; Flores O; Ortíz MC; Hidalgo F; Rodríguez-López AM; Eleno N; Atucha NM; Sánchez-Rodríguez A; Arévalo M; Garcia-Estañ J; López-Novoa JM
    Hepatology; 1997 Aug; 26(2):268-76. PubMed ID: 9252133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats.
    Wei CL; Hon WM; Lee KH; Khoo HE
    Liver Int; 2005 Jun; 25(3):647-56. PubMed ID: 15910502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal effects of the chronic inhibition of nitric oxide synthesis in cirrhotic rats with ascites].
    Ortiz MC; Fortepiani LA; Martínez-Salgado C; Eleno N; Atucha NM; López-Novoa JM; García-Estañ J
    Nefrologia; 2001; 21(6):556-64. PubMed ID: 11881425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: role of nitric oxide and bradykinin.
    Chen CT; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Wu SL; Chan CC; Huang HC; Lee SD
    Hepatogastroenterology; 2009; 56(94-95):1261-7. PubMed ID: 19950773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between prostanoids and nitric oxide in the control of tubular function in rats with chronic bile duct ligation.
    Criado M; Flores O; Hidalgo F; López-Novoa JM; Sánchez-Rodríguez A
    Can J Physiol Pharmacol; 1999 Feb; 77(2):111-7. PubMed ID: 10535701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelium-dependent vascular hyporesponsiveness without detection of nitric oxide synthase induction in aortas of cirrhotic rats.
    Weigert AL; Martin PY; Niederberger M; Higa EM; McMurtry IF; Gines P; Schrier RW
    Hepatology; 1995 Dec; 22(6):1856-62. PubMed ID: 7489998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation.
    Mayoral P; Criado M; Hidalgo F; Flores O; Arévalo MA; Eleno N; Sánchez-Rodríguez A; López-Novoa JM; Esteller A
    Clin Sci (Lond); 1999 Mar; 96(3):297-305. PubMed ID: 10029566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic L-NAME on nitrotyrosine expression and renal vascular reactivity in rats with chronic bile-duct ligation.
    Alcaraz A; Hernández D; Iyú D; Mota R; Atucha NM; Ortiz AJ; García-Estañ J; Ortiz MC
    Clin Sci (Lond); 2008 Jul; 115(2):57-68. PubMed ID: 18184108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that inducible nitric oxide synthase is involved in LPS-induced plasma leakage in rat skin through the activation of nuclear factor-kappaB.
    Iuvone T; D'Acquisto F; Van Osselaer N; Di Rosa M; Carnuccio R; Herman AG
    Br J Pharmacol; 1998 Apr; 123(7):1325-30. PubMed ID: 9579726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
    Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of cholestatic rats against epinephrine-induced arrhythmia: the role of nitric oxide and endogenous opioids.
    Hajrasouliha AR; Tavakoli S; Jabehdar-Maralani P; Shafaroodi H; Borhani AA; Houshmand G; Sadeghipour H; Dehghani M; Dehpour AR
    Eur J Pharmacol; 2004 Sep; 499(3):307-13. PubMed ID: 15381053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of renal medullary inducible nitric oxide synthase in the regulation of arterial pressure.
    Tan DY; Caramelo C
    Sheng Li Xue Bao; 2000 Apr; 52(2):103-8. PubMed ID: 11961577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential changes in redox status and nitric oxide synthases expression in the liver after bile duct ligation.
    Vázquez-Gil MJ; Mesonero MJ; Flores O; Criado M; Hidalgo F; Arévalo MA; Sánchez-Rodríguez A; Tuñón MJ; López-Novoa JM; Esteller A
    Life Sci; 2004 Jun; 75(6):717-32. PubMed ID: 15172180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of selective nitric oxide synthase inhibitor on nitric oxide and PGE2 levels in refractory hemorrhagic-shocked rats.
    Md S; Moochhala SM; Siew Yang KL; Lu J; Anuar F; Mok P; Ng KC
    J Surg Res; 2005 Feb; 123(2):206-14. PubMed ID: 15680380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide synthases inhibition results in renal failure improvement in cirrhotic rats.
    Islas-Carbajal MC; Covarrubias A; Grijalva G; Alvarez-Rodríguez A; Armendáriz-Borunda J; Rincón-Sánchez AR
    Liver Int; 2005 Feb; 25(1):131-40. PubMed ID: 15698410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
    Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
    Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual action of nitric oxide in pathogenesis of indomethacin-induced small intestinal ulceration in rats.
    Tanaka A; Kunikata T; Mizoguchi H; Kato S; Takeuchi K
    J Physiol Pharmacol; 1999 Sep; 50(3):405-17. PubMed ID: 10574470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of endogenous opioid peptides and nitric oxide in the blunted chronotropic and inotropic responses to beta-adrenergic stimulation in cirrhotic rats.
    Ebrahimi F; Tavakoli S; Hajrasouliha AR; Sadeghipour H; Dehghani M; Ahmadi SH; Dehpour AR
    Fundam Clin Pharmacol; 2006 Oct; 20(5):461-71. PubMed ID: 16968416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide synthase 1 is partly compensating for nitric oxide synthase 3 deficiency in nitric oxide synthase 3 knock-out mice and is elevated in murine and human cirrhosis.
    Biecker E; Neef M; Sägesser H; Shaw S; Koshy A; Reichen J
    Liver Int; 2004 Aug; 24(4):345-53. PubMed ID: 15287858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats.
    Soulis T; Cooper ME; Sastra S; Thallas V; Panagiotopoulos S; Bjerrum OJ; Jerums G
    Diabetologia; 1997 Oct; 40(10):1141-51. PubMed ID: 9349594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.